YAZ Premenstrual Dysphoric Disorder (PMDD) in China
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of YAZ compared to placebo
in the treatment of symptoms related to Premenstrual Dysphoric Disorder (PMDD).